Chemistry in the Clinic: Reading the Body's Molecular Signals
Every year, laboratories around the world perform billions of clinical chemistry tests on blood, urine, and other biological fluids. These tests detect the concentrations of hundreds of analytes — glucose, cholesterol, enzymes, hormones, proteins, electrolytes — and use their levels to diagnose disease, monitor treatment, and guide clinical decisions. Clinical chemistry is applied biochemistry: the science of translating molecular signals into medical insight.
Blood as a Chemical Window Into the Body
Blood is a complex fluid carrying nutrients, wastes, signaling molecules, immune cells, and clotting factors. A standard clinical chemistry panel analyzes the serum or plasma (the liquid fraction after cells are removed). Key categories of analytes include:
- Metabolites: glucose, urea, creatinine, uric acid, bilirubin
- Electrolytes: Na⁺, K⁺, Cl⁻, HCO₃⁻, Ca²⁺, Mg²⁺, PO₄³⁻
- Enzymes: AST, ALT, ALP, LDH, creatine kinase (CK), lipase, amylase
- Proteins: albumin, total protein, C-reactive protein (CRP), troponin, prealbumin
- Lipids: total cholesterol, HDL-C, LDL-C, triglycerides
- Hormones: TSH, T₃, T₄, cortisol, testosterone, estradiol, insulin
- Tumor markers: PSA, CA-125, AFP, CEA, CA 19-9
Glucose and Diabetes Diagnosis
Blood glucose measurement is one of the most common laboratory tests. Glucose is measured in serum using glucose oxidase or hexokinase enzyme-based spectrophotometric assays:
Glucose + O₂ → Gluconolactone + H₂O₂ (glucose oxidase) H₂O₂ + chromogen → colored product (measured at ~500 nm)
Reference ranges (fasting): - Normal: 70–99 mg/dL (3.9–5.5 mmol/L) - Prediabetes: 100–125 mg/dL - Diabetes: ≥126 mg/dL (on two occasions)
HbA1c: The Three-Month Glucose Average
Glycated hemoglobin (HbA1c) reflects average blood glucose over approximately 3 months — the lifespan of a red blood cell. Glucose spontaneously reacts with the N-terminal valine of hemoglobin β-chains via a Schiff base (reversible) that rearranges to a stable Amadori product:
Hb-NH₂ + Glucose → Hb-N=CH-R (Schiff base) → Hb-NH-CH(OH)-R (Amadori product)
The percentage of hemoglobin that is glycated (HbA1c %) reflects long-term glucose control. HbA1c ≥6.5% is diagnostic of diabetes; the therapeutic target for most diabetic patients is <7%. HbA1c is measured by HPLC, capillary electrophoresis, or immunoassay.
Kidney Function Tests
The kidneys filter ~180 L of blood per day and excrete waste products. Two key markers assess kidney function:
Creatinine and GFR
Creatinine is a waste product of creatine phosphate metabolism in muscle (creatine → creatinine, spontaneous, irreversible). It is filtered freely by the glomerulus and not reabsorbed, making it an excellent marker of glomerular filtration rate (GFR).
The classic Jaffé reaction detects creatinine: creatinine reacts with alkaline picrate to form an orange-red complex (Jaffé product) measured at 510 nm. Enzymatic methods (creatinase → sarcosine → H₂O₂ → chromogen) are more specific.
eGFR (estimated GFR) is calculated from serum creatinine, age, sex, and race using equations like CKD-EPI. Normal eGFR >60 mL/min/1.73 m². Chronic kidney disease is defined as eGFR <60 for >3 months.
Blood Urea Nitrogen (BUN)
Urea (CO(NH₂)₂) is the major end product of nitrogen metabolism from amino acid catabolism, produced in the liver via the urea cycle. Urea is measured by the urease-Berthelot reaction:
Urea + H₂O → 2NH₃ + CO₂ (urease) NH₃ + alkaline phenol + hypochlorite → blue indophenol (Berthelot reaction)
The BUN:creatinine ratio helps differentiate pre-renal (dehydration, >20:1) from intrinsic renal failure (~10–15:1).
Liver Function Tests
Liver cells release characteristic enzymes when damaged. The liver enzyme panel typically includes:
AST and ALT (Aminotransferases)
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) catalyze amino group transfers and require pyridoxal phosphate (B₆) as a cofactor. Both are measured spectrophotometrically by coupling the aminotransferase reaction to an indicator reaction (e.g., NADH oxidation at 340 nm).
ALT is more liver-specific. Elevated ALT and AST signal hepatocyte damage: hepatitis (viral, alcoholic, drug-induced), fatty liver disease, or liver necrosis.
Alkaline Phosphatase (ALP)
ALP is highest in bone, liver, and bile duct epithelium. Elevated ALP with elevated γ-glutamyl transferase (GGT) suggests cholestasis (bile flow obstruction) rather than hepatocellular damage.
Bilirubin
Bilirubin is the breakdown product of heme from aging red blood cells:
Heme → Biliverdin → Bilirubin (unconjugated, water-insoluble)
The liver conjugates bilirubin with glucuronic acid (making it water-soluble) for excretion in bile. The diazo reaction (Van den Bergh method) measures: - Direct bilirubin: conjugated bilirubin reacts directly - Indirect bilirubin: unconjugated; calculated as total − direct
Elevated indirect bilirubin indicates hemolysis or impaired conjugation (Gilbert's syndrome, Crigler-Najjar syndrome). Elevated direct bilirubin indicates cholestasis or hepatocellular disease.
Cardiac Biomarkers: Diagnosing Heart Attacks
Myocardial infarction (MI, heart attack) is a medical emergency requiring rapid diagnosis. Specific proteins leak from damaged heart muscle cells into the bloodstream.
Troponin
Cardiac troponin I (cTnI) and troponin T (cTnT) are components of the troponin-tropomyosin regulatory complex controlling muscle contraction. Cardiac isoforms differ from skeletal muscle isoforms, making them highly specific for myocardial damage.
High-sensitivity troponin (hs-Tn) assays can detect concentrations as low as 1–5 ng/L, enabling earlier and more precise MI diagnosis. Troponin rises within 2–3 hours of MI onset, peaks at 12–24 hours, and remains elevated for 7–14 days. Serial measurements (0h/1h or 0h/2h protocols) can rule in or rule out MI rapidly.
CK-MB
Creatine kinase MB isoform (CK-MB) was the gold standard cardiac marker before troponin. CK catalyzes: creatine + ATP ⇌ creatine phosphate + ADP. The MB dimer (containing both M and B subunits) is enriched in cardiac muscle. Now used mainly to assess re-infarction (its faster rise-and-fall kinetics compared to troponin).
BNP and NT-proBNP
B-type natriuretic peptide (BNP) and its N-terminal fragment (NT-proBNP) are released by cardiomyocytes under mechanical stress (elevated filling pressures). They are primary biomarkers for diagnosing and monitoring heart failure. Both are measured by immunoassay.
Lipid Panel and Cardiovascular Risk
The standard lipid panel measures: - Total cholesterol: colorimetric enzymatic assay (cholesterol esterase + cholesterol oxidase + H₂O₂ + chromogen) - Triglycerides: lipase → glycerol → glycerol-3-phosphate → H₂O₂ → chromogen - HDL cholesterol: precipitation of LDL and VLDL, then measure residual HDL - LDL cholesterol: typically calculated by the Friedewald equation: LDL = Total − HDL − (Triglycerides/5) [mg/dL]
Elevated LDL-C (>160 mg/dL, high risk) and low HDL-C (<40 mg/dL in men) are major cardiovascular risk factors.
Point-of-Care Testing and Immunoassays
Modern clinical chemistry has moved increasingly toward point-of-care (POC) testing — rapid tests performed at or near the patient, outside the central laboratory.
Immunoassays use antibody-antigen interactions for sensitive and specific detection: - ELISA (enzyme-linked immunosorbent assay): antigen captured on a plate, detected with enzyme-linked antibody; color change quantified - Lateral flow assays: the technology behind home pregnancy tests and COVID-19 rapid antigen tests; colloidal gold-labeled antibodies migrate along a membrane, accumulating at test lines when antigen is present - Chemiluminescent immunoassay (CLIA): used in automated hospital analyzers; produces light quantified by a photomultiplier; enables detection at picomolar concentrations
Biomarkers and Precision Medicine
The concept of a biomarker — a measurable molecular indicator of a biological state or disease — extends clinical chemistry into the emerging era of precision medicine. Examples include:
- BRCA1/2 mutations: predict hereditary breast and ovarian cancer risk
- HER2/neu overexpression: in breast cancer, guides trastuzumab (Herceptin) therapy
- BCR-ABL fusion oncoprotein: diagnostic in CML; monitored by PCR after imatinib therapy
- Circulating tumor DNA (ctDNA): cell-free DNA shed by tumors into blood; a "liquid biopsy" enabling early cancer detection and monitoring treatment response
- Serum ferritin, transferrin saturation: iron status assessment
- Hemoglobin A2 and F: diagnosing β-thalassemia subtypes
Reference Ranges and Clinical Decision-Making
Interpreting clinical chemistry results requires understanding reference ranges — the range of values in a healthy population (typically defined as mean ± 2 SD, covering 95% of healthy individuals). Reference ranges vary by laboratory, method, age, sex, and clinical context.
Critical values — results so abnormal they require immediate clinical action — include: serum K⁺ <2.5 or >6.5 mmol/L, blood glucose <45 or >500 mg/dL, serum sodium <120 or >160 mmol/L. These represent chemical emergencies that can cause arrhythmias, seizures, or cardiac arrest.
Clinical chemistry bridges the molecular world of enzymes, ions, and metabolites with the clinical world of diagnosis and treatment — transforming the language of chemistry into the language of patient care.